Skip to main content
. 2012 Aug 16;12:667. doi: 10.1186/1471-2458-12-667

Table 2.

Summary of baseline and follow-up assessments

Measure
Month of treatment
  Baseline 3 (End of active treatment phase) 6 12 18 24
Weight
X
X
X
X
X
X
Waist circumference
X
X
X
X
X
X
Questionnaire-based measures
X
X
X
X
X
X
Blood pressure
X
X
 
 
 
 
Blood cholesterol/LDL/glucose levels X X        
HHS Vulnerability Disclosure